Browsing by Autor "Dayany Moreno Samper"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Item type: Item ,
    Seguridad de las vacunas contra la COVID-19
    (National Institute of Health of Peru, 2021) Nataniel Aldo Chaparro Mérida; Dayany Moreno Samper; Alex Omar Franco Lacato
    The development and production of safe and effective vaccines against coronavirus disease 2019 (COVID-19) provides hope for controlling the current pandemic. Adverse events following immunization are unwanted responses or unintended events that must be carefully monitored, as all vaccines, including those developed against SARS-CoV-2, are required to meet safety criteria for administration in humans. Information was collected from the PubMed/Medline database during the months of August 2020 to November 2021. Most adverse events reported in clinical trials were mild or moderate; however, thrombotic events associated with some viral vector-based vaccines against COVID-19 were identified in follow-up studies, although completion of the various ongoing studies and post-marketing surveillance is required to determine all potential adverse events, as well as those of special interest.
  • Thumbnail Image
    Item type: Item ,
    Viruela símica en un paciente con VIH: reporte de caso
    (National Institute of Health of Peru, 2023) Alex Omar Franco Lacato; Nataniel- Aldo Chaparro-Mérida; Dayany Moreno Samper; D. Padilla; Daniel Vides Melendres; Jhossmar Cristians Auza-Santiváñez
    Monkeypox (Mpox) is a zoonotic disease, endemic in some areas of Africa. But since May 2022, multiple cases of Mpox have been reported in non-endemic countries. We present the case of a patient with a history of HIV, as well as rash in several areas of the body, mostly in the gluteal region, associated with cervical lymphadenopathy and infectious proctitis. Diagnosis was confirmed by real-time polymerase chain reaction (RT-PCR) of skin lesion samples. Treponema pallidum and Neisseria gonorrhoeae infection was confirmed by serology and rectal discharge culture, respectively. The patient received antibiotics specific for gonorrhea and syphilis and his condition improved due to symptomatic and immunomodulatory therapy.